In the United States, patients with coronavirus infection will be treated with blood plasma transfusions from patients who have recovered from the disease. The corresponding authorization was issued by the Food and Drug Administration (FDA).
The department noted that available scientific publications indicate that this method of treatment can be an effective method of combating the disease, and the potential benefits outweigh the potential risks.
“This emergency clearance for plasma treatment of recovered patients is a major milestone and achievement in President (Donad) Trump’s efforts to save lives from COVID-19,” said US Secretary of Health and Human Services Alex Azar on August 23.
This method of treatment has been tested on 70,000 Americans, the FDA said.
On August 22, an American virologist said that high population mobility and weak quarantine measures contributed to the widespread spread of COVID-19 in the country. At the same time, the specialist denied reports that the second wave of coronavirus would come in the United States.
The United States ranks first in the world for the number of people infected with COVID-19.
According to Worldometer, as of August 24, more than 5.8 million cases of infection were detected in the country, of which more than 180 thousand were fatal. Since the beginning of the pandemic, more than 3.1 million coronavirus patients have recovered in the country.